Medical Care
Global Personalized Cancer Treatment Market Research Report 2025
- Apr 07, 25
- ID: 171441
- Pages: 84
- Figures: 89
- Views: 20
The global market for Personalized Cancer Treatment was valued at US$ 198 million in the year 2024 and is projected to reach a revised size of US$ 301 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Personalized cancer treatment, also known as precision medicine or individualized medicine, is a treatment strategy that tailors treatment plans based on the patient's molecular characteristics such as genes, proteins, metabolites, and the unique biological characteristics of the tumor.
North American market for Personalized Cancer Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Personalized Cancer Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Personalized Cancer Treatment in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Personalized Cancer Treatment include Cellworks, Novartis, Gradalis, Inc, TherapySelect, Personalis, RGCC International, Genentech, BMS, OHC - Oncology Hematology Care, CTOAM, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Personalized Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cancer Treatment.
The Personalized Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cellworks
Novartis
Gradalis, Inc
TherapySelect
Personalis
RGCC International
Genentech
BMS
OHC - Oncology Hematology Care
CTOAM
Aadi Bioscience
Segment by Type
Personalized Medical Diagnosis
Personalized Medical Treatment
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Cancer Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Personalized cancer treatment, also known as precision medicine or individualized medicine, is a treatment strategy that tailors treatment plans based on the patient's molecular characteristics such as genes, proteins, metabolites, and the unique biological characteristics of the tumor.
North American market for Personalized Cancer Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Personalized Cancer Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Personalized Cancer Treatment in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Personalized Cancer Treatment include Cellworks, Novartis, Gradalis, Inc, TherapySelect, Personalis, RGCC International, Genentech, BMS, OHC - Oncology Hematology Care, CTOAM, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Personalized Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cancer Treatment.
The Personalized Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cellworks
Novartis
Gradalis, Inc
TherapySelect
Personalis
RGCC International
Genentech
BMS
OHC - Oncology Hematology Care
CTOAM
Aadi Bioscience
Segment by Type
Personalized Medical Diagnosis
Personalized Medical Treatment
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Cancer Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Personalized Medical Diagnosis
1.2.3 Personalized Medical Treatment
1.3 Market by Application
1.3.1 Global Personalized Cancer Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cancer Treatment Market Perspective (2020-2031)
2.2 Global Personalized Cancer Treatment Growth Trends by Region
2.2.1 Global Personalized Cancer Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Personalized Cancer Treatment Historic Market Size by Region (2020-2025)
2.2.3 Personalized Cancer Treatment Forecasted Market Size by Region (2026-2031)
2.3 Personalized Cancer Treatment Market Dynamics
2.3.1 Personalized Cancer Treatment Industry Trends
2.3.2 Personalized Cancer Treatment Market Drivers
2.3.3 Personalized Cancer Treatment Market Challenges
2.3.4 Personalized Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Cancer Treatment Players by Revenue
3.1.1 Global Top Personalized Cancer Treatment Players by Revenue (2020-2025)
3.1.2 Global Personalized Cancer Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Top Personalized Cancer Treatment Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Personalized Cancer Treatment Revenue
3.4 Global Personalized Cancer Treatment Market Concentration Ratio
3.4.1 Global Personalized Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Treatment Revenue in 2024
3.5 Global Key Players of Personalized Cancer Treatment Head office and Area Served
3.6 Global Key Players of Personalized Cancer Treatment, Product and Application
3.7 Global Key Players of Personalized Cancer Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cancer Treatment Breakdown Data by Type
4.1 Global Personalized Cancer Treatment Historic Market Size by Type (2020-2025)
4.2 Global Personalized Cancer Treatment Forecasted Market Size by Type (2026-2031)
5 Personalized Cancer Treatment Breakdown Data by Application
5.1 Global Personalized Cancer Treatment Historic Market Size by Application (2020-2025)
5.2 Global Personalized Cancer Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Personalized Cancer Treatment Market Size (2020-2031)
6.2 North America Personalized Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Personalized Cancer Treatment Market Size by Country (2020-2025)
6.4 North America Personalized Cancer Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Cancer Treatment Market Size (2020-2031)
7.2 Europe Personalized Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Personalized Cancer Treatment Market Size by Country (2020-2025)
7.4 Europe Personalized Cancer Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Cancer Treatment Market Size (2020-2031)
8.2 Asia-Pacific Personalized Cancer Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Personalized Cancer Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Personalized Cancer Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Cancer Treatment Market Size (2020-2031)
9.2 Latin America Personalized Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Personalized Cancer Treatment Market Size by Country (2020-2025)
9.4 Latin America Personalized Cancer Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Cancer Treatment Market Size (2020-2031)
10.2 Middle East & Africa Personalized Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Personalized Cancer Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Personalized Cancer Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellworks
11.1.1 Cellworks Company Details
11.1.2 Cellworks Business Overview
11.1.3 Cellworks Personalized Cancer Treatment Introduction
11.1.4 Cellworks Revenue in Personalized Cancer Treatment Business (2020-2025)
11.1.5 Cellworks Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Personalized Cancer Treatment Introduction
11.2.4 Novartis Revenue in Personalized Cancer Treatment Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Gradalis, Inc
11.3.1 Gradalis, Inc Company Details
11.3.2 Gradalis, Inc Business Overview
11.3.3 Gradalis, Inc Personalized Cancer Treatment Introduction
11.3.4 Gradalis, Inc Revenue in Personalized Cancer Treatment Business (2020-2025)
11.3.5 Gradalis, Inc Recent Development
11.4 TherapySelect
11.4.1 TherapySelect Company Details
11.4.2 TherapySelect Business Overview
11.4.3 TherapySelect Personalized Cancer Treatment Introduction
11.4.4 TherapySelect Revenue in Personalized Cancer Treatment Business (2020-2025)
11.4.5 TherapySelect Recent Development
11.5 Personalis
11.5.1 Personalis Company Details
11.5.2 Personalis Business Overview
11.5.3 Personalis Personalized Cancer Treatment Introduction
11.5.4 Personalis Revenue in Personalized Cancer Treatment Business (2020-2025)
11.5.5 Personalis Recent Development
11.6 RGCC International
11.6.1 RGCC International Company Details
11.6.2 RGCC International Business Overview
11.6.3 RGCC International Personalized Cancer Treatment Introduction
11.6.4 RGCC International Revenue in Personalized Cancer Treatment Business (2020-2025)
11.6.5 RGCC International Recent Development
11.7 Genentech
11.7.1 Genentech Company Details
11.7.2 Genentech Business Overview
11.7.3 Genentech Personalized Cancer Treatment Introduction
11.7.4 Genentech Revenue in Personalized Cancer Treatment Business (2020-2025)
11.7.5 Genentech Recent Development
11.8 BMS
11.8.1 BMS Company Details
11.8.2 BMS Business Overview
11.8.3 BMS Personalized Cancer Treatment Introduction
11.8.4 BMS Revenue in Personalized Cancer Treatment Business (2020-2025)
11.8.5 BMS Recent Development
11.9 OHC - Oncology Hematology Care
11.9.1 OHC - Oncology Hematology Care Company Details
11.9.2 OHC - Oncology Hematology Care Business Overview
11.9.3 OHC - Oncology Hematology Care Personalized Cancer Treatment Introduction
11.9.4 OHC - Oncology Hematology Care Revenue in Personalized Cancer Treatment Business (2020-2025)
11.9.5 OHC - Oncology Hematology Care Recent Development
11.10 CTOAM
11.10.1 CTOAM Company Details
11.10.2 CTOAM Business Overview
11.10.3 CTOAM Personalized Cancer Treatment Introduction
11.10.4 CTOAM Revenue in Personalized Cancer Treatment Business (2020-2025)
11.10.5 CTOAM Recent Development
11.11 Aadi Bioscience
11.11.1 Aadi Bioscience Company Details
11.11.2 Aadi Bioscience Business Overview
11.11.3 Aadi Bioscience Personalized Cancer Treatment Introduction
11.11.4 Aadi Bioscience Revenue in Personalized Cancer Treatment Business (2020-2025)
11.11.5 Aadi Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Personalized Medical Diagnosis
1.2.3 Personalized Medical Treatment
1.3 Market by Application
1.3.1 Global Personalized Cancer Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cancer Treatment Market Perspective (2020-2031)
2.2 Global Personalized Cancer Treatment Growth Trends by Region
2.2.1 Global Personalized Cancer Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Personalized Cancer Treatment Historic Market Size by Region (2020-2025)
2.2.3 Personalized Cancer Treatment Forecasted Market Size by Region (2026-2031)
2.3 Personalized Cancer Treatment Market Dynamics
2.3.1 Personalized Cancer Treatment Industry Trends
2.3.2 Personalized Cancer Treatment Market Drivers
2.3.3 Personalized Cancer Treatment Market Challenges
2.3.4 Personalized Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Cancer Treatment Players by Revenue
3.1.1 Global Top Personalized Cancer Treatment Players by Revenue (2020-2025)
3.1.2 Global Personalized Cancer Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Top Personalized Cancer Treatment Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Personalized Cancer Treatment Revenue
3.4 Global Personalized Cancer Treatment Market Concentration Ratio
3.4.1 Global Personalized Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Treatment Revenue in 2024
3.5 Global Key Players of Personalized Cancer Treatment Head office and Area Served
3.6 Global Key Players of Personalized Cancer Treatment, Product and Application
3.7 Global Key Players of Personalized Cancer Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cancer Treatment Breakdown Data by Type
4.1 Global Personalized Cancer Treatment Historic Market Size by Type (2020-2025)
4.2 Global Personalized Cancer Treatment Forecasted Market Size by Type (2026-2031)
5 Personalized Cancer Treatment Breakdown Data by Application
5.1 Global Personalized Cancer Treatment Historic Market Size by Application (2020-2025)
5.2 Global Personalized Cancer Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Personalized Cancer Treatment Market Size (2020-2031)
6.2 North America Personalized Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Personalized Cancer Treatment Market Size by Country (2020-2025)
6.4 North America Personalized Cancer Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Cancer Treatment Market Size (2020-2031)
7.2 Europe Personalized Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Personalized Cancer Treatment Market Size by Country (2020-2025)
7.4 Europe Personalized Cancer Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Cancer Treatment Market Size (2020-2031)
8.2 Asia-Pacific Personalized Cancer Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Personalized Cancer Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Personalized Cancer Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Cancer Treatment Market Size (2020-2031)
9.2 Latin America Personalized Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Personalized Cancer Treatment Market Size by Country (2020-2025)
9.4 Latin America Personalized Cancer Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Cancer Treatment Market Size (2020-2031)
10.2 Middle East & Africa Personalized Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Personalized Cancer Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Personalized Cancer Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellworks
11.1.1 Cellworks Company Details
11.1.2 Cellworks Business Overview
11.1.3 Cellworks Personalized Cancer Treatment Introduction
11.1.4 Cellworks Revenue in Personalized Cancer Treatment Business (2020-2025)
11.1.5 Cellworks Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Personalized Cancer Treatment Introduction
11.2.4 Novartis Revenue in Personalized Cancer Treatment Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Gradalis, Inc
11.3.1 Gradalis, Inc Company Details
11.3.2 Gradalis, Inc Business Overview
11.3.3 Gradalis, Inc Personalized Cancer Treatment Introduction
11.3.4 Gradalis, Inc Revenue in Personalized Cancer Treatment Business (2020-2025)
11.3.5 Gradalis, Inc Recent Development
11.4 TherapySelect
11.4.1 TherapySelect Company Details
11.4.2 TherapySelect Business Overview
11.4.3 TherapySelect Personalized Cancer Treatment Introduction
11.4.4 TherapySelect Revenue in Personalized Cancer Treatment Business (2020-2025)
11.4.5 TherapySelect Recent Development
11.5 Personalis
11.5.1 Personalis Company Details
11.5.2 Personalis Business Overview
11.5.3 Personalis Personalized Cancer Treatment Introduction
11.5.4 Personalis Revenue in Personalized Cancer Treatment Business (2020-2025)
11.5.5 Personalis Recent Development
11.6 RGCC International
11.6.1 RGCC International Company Details
11.6.2 RGCC International Business Overview
11.6.3 RGCC International Personalized Cancer Treatment Introduction
11.6.4 RGCC International Revenue in Personalized Cancer Treatment Business (2020-2025)
11.6.5 RGCC International Recent Development
11.7 Genentech
11.7.1 Genentech Company Details
11.7.2 Genentech Business Overview
11.7.3 Genentech Personalized Cancer Treatment Introduction
11.7.4 Genentech Revenue in Personalized Cancer Treatment Business (2020-2025)
11.7.5 Genentech Recent Development
11.8 BMS
11.8.1 BMS Company Details
11.8.2 BMS Business Overview
11.8.3 BMS Personalized Cancer Treatment Introduction
11.8.4 BMS Revenue in Personalized Cancer Treatment Business (2020-2025)
11.8.5 BMS Recent Development
11.9 OHC - Oncology Hematology Care
11.9.1 OHC - Oncology Hematology Care Company Details
11.9.2 OHC - Oncology Hematology Care Business Overview
11.9.3 OHC - Oncology Hematology Care Personalized Cancer Treatment Introduction
11.9.4 OHC - Oncology Hematology Care Revenue in Personalized Cancer Treatment Business (2020-2025)
11.9.5 OHC - Oncology Hematology Care Recent Development
11.10 CTOAM
11.10.1 CTOAM Company Details
11.10.2 CTOAM Business Overview
11.10.3 CTOAM Personalized Cancer Treatment Introduction
11.10.4 CTOAM Revenue in Personalized Cancer Treatment Business (2020-2025)
11.10.5 CTOAM Recent Development
11.11 Aadi Bioscience
11.11.1 Aadi Bioscience Company Details
11.11.2 Aadi Bioscience Business Overview
11.11.3 Aadi Bioscience Personalized Cancer Treatment Introduction
11.11.4 Aadi Bioscience Revenue in Personalized Cancer Treatment Business (2020-2025)
11.11.5 Aadi Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Personalized Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Personalized Medical Diagnosis
Table 3. Key Players of Personalized Medical Treatment
Table 4. Global Personalized Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Personalized Cancer Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Personalized Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Personalized Cancer Treatment Market Share by Region (2020-2025)
Table 8. Global Personalized Cancer Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Personalized Cancer Treatment Market Share by Region (2026-2031)
Table 10. Personalized Cancer Treatment Market Trends
Table 11. Personalized Cancer Treatment Market Drivers
Table 12. Personalized Cancer Treatment Market Challenges
Table 13. Personalized Cancer Treatment Market Restraints
Table 14. Global Personalized Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Personalized Cancer Treatment Market Share by Players (2020-2025)
Table 16. Global Top Personalized Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Treatment as of 2024)
Table 17. Ranking of Global Top Personalized Cancer Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Personalized Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Personalized Cancer Treatment, Headquarters and Area Served
Table 20. Global Key Players of Personalized Cancer Treatment, Product and Application
Table 21. Global Key Players of Personalized Cancer Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Personalized Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Personalized Cancer Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Personalized Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Personalized Cancer Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Personalized Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Personalized Cancer Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Personalized Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Personalized Cancer Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Personalized Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Personalized Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Personalized Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Personalized Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Personalized Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Personalized Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Personalized Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Personalized Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Personalized Cancer Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Personalized Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Personalized Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Personalized Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Personalized Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Personalized Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Personalized Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Cellworks Company Details
Table 47. Cellworks Business Overview
Table 48. Cellworks Personalized Cancer Treatment Product
Table 49. Cellworks Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 50. Cellworks Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Personalized Cancer Treatment Product
Table 54. Novartis Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gradalis, Inc Company Details
Table 57. Gradalis, Inc Business Overview
Table 58. Gradalis, Inc Personalized Cancer Treatment Product
Table 59. Gradalis, Inc Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 60. Gradalis, Inc Recent Development
Table 61. TherapySelect Company Details
Table 62. TherapySelect Business Overview
Table 63. TherapySelect Personalized Cancer Treatment Product
Table 64. TherapySelect Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 65. TherapySelect Recent Development
Table 66. Personalis Company Details
Table 67. Personalis Business Overview
Table 68. Personalis Personalized Cancer Treatment Product
Table 69. Personalis Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 70. Personalis Recent Development
Table 71. RGCC International Company Details
Table 72. RGCC International Business Overview
Table 73. RGCC International Personalized Cancer Treatment Product
Table 74. RGCC International Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 75. RGCC International Recent Development
Table 76. Genentech Company Details
Table 77. Genentech Business Overview
Table 78. Genentech Personalized Cancer Treatment Product
Table 79. Genentech Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 80. Genentech Recent Development
Table 81. BMS Company Details
Table 82. BMS Business Overview
Table 83. BMS Personalized Cancer Treatment Product
Table 84. BMS Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 85. BMS Recent Development
Table 86. OHC - Oncology Hematology Care Company Details
Table 87. OHC - Oncology Hematology Care Business Overview
Table 88. OHC - Oncology Hematology Care Personalized Cancer Treatment Product
Table 89. OHC - Oncology Hematology Care Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 90. OHC - Oncology Hematology Care Recent Development
Table 91. CTOAM Company Details
Table 92. CTOAM Business Overview
Table 93. CTOAM Personalized Cancer Treatment Product
Table 94. CTOAM Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 95. CTOAM Recent Development
Table 96. Aadi Bioscience Company Details
Table 97. Aadi Bioscience Business Overview
Table 98. Aadi Bioscience Personalized Cancer Treatment Product
Table 99. Aadi Bioscience Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 100. Aadi Bioscience Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Personalized Cancer Treatment Picture
Figure 2. Global Personalized Cancer Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Personalized Cancer Treatment Market Share by Type: 2024 VS 2031
Figure 4. Personalized Medical Diagnosis Features
Figure 5. Personalized Medical Treatment Features
Figure 6. Global Personalized Cancer Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Personalized Cancer Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Personalized Cancer Treatment Report Years Considered
Figure 11. Global Personalized Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Personalized Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Personalized Cancer Treatment Market Share by Region: 2024 VS 2031
Figure 14. Global Personalized Cancer Treatment Market Share by Players in 2024
Figure 15. Global Personalized Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Personalized Cancer Treatment Revenue in 2024
Figure 17. North America Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Personalized Cancer Treatment Market Share by Country (2020-2031)
Figure 19. United States Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Personalized Cancer Treatment Market Share by Country (2020-2031)
Figure 23. Germany Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Personalized Cancer Treatment Market Share by Region (2020-2031)
Figure 31. China Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Personalized Cancer Treatment Market Share by Country (2020-2031)
Figure 39. Mexico Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Personalized Cancer Treatment Market Share by Country (2020-2031)
Figure 43. Turkey Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Cellworks Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 47. Novartis Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 48. Gradalis, Inc Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 49. TherapySelect Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 50. Personalis Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 51. RGCC International Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 52. Genentech Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 53. BMS Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 54. OHC - Oncology Hematology Care Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 55. CTOAM Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 56. Aadi Bioscience Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Personalized Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Personalized Medical Diagnosis
Table 3. Key Players of Personalized Medical Treatment
Table 4. Global Personalized Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Personalized Cancer Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Personalized Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Personalized Cancer Treatment Market Share by Region (2020-2025)
Table 8. Global Personalized Cancer Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Personalized Cancer Treatment Market Share by Region (2026-2031)
Table 10. Personalized Cancer Treatment Market Trends
Table 11. Personalized Cancer Treatment Market Drivers
Table 12. Personalized Cancer Treatment Market Challenges
Table 13. Personalized Cancer Treatment Market Restraints
Table 14. Global Personalized Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Personalized Cancer Treatment Market Share by Players (2020-2025)
Table 16. Global Top Personalized Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Treatment as of 2024)
Table 17. Ranking of Global Top Personalized Cancer Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Personalized Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Personalized Cancer Treatment, Headquarters and Area Served
Table 20. Global Key Players of Personalized Cancer Treatment, Product and Application
Table 21. Global Key Players of Personalized Cancer Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Personalized Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Personalized Cancer Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Personalized Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Personalized Cancer Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Personalized Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Personalized Cancer Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Personalized Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Personalized Cancer Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Personalized Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Personalized Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Personalized Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Personalized Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Personalized Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Personalized Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Personalized Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Personalized Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Personalized Cancer Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Personalized Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Personalized Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Personalized Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Personalized Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Personalized Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Personalized Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Cellworks Company Details
Table 47. Cellworks Business Overview
Table 48. Cellworks Personalized Cancer Treatment Product
Table 49. Cellworks Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 50. Cellworks Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Personalized Cancer Treatment Product
Table 54. Novartis Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gradalis, Inc Company Details
Table 57. Gradalis, Inc Business Overview
Table 58. Gradalis, Inc Personalized Cancer Treatment Product
Table 59. Gradalis, Inc Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 60. Gradalis, Inc Recent Development
Table 61. TherapySelect Company Details
Table 62. TherapySelect Business Overview
Table 63. TherapySelect Personalized Cancer Treatment Product
Table 64. TherapySelect Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 65. TherapySelect Recent Development
Table 66. Personalis Company Details
Table 67. Personalis Business Overview
Table 68. Personalis Personalized Cancer Treatment Product
Table 69. Personalis Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 70. Personalis Recent Development
Table 71. RGCC International Company Details
Table 72. RGCC International Business Overview
Table 73. RGCC International Personalized Cancer Treatment Product
Table 74. RGCC International Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 75. RGCC International Recent Development
Table 76. Genentech Company Details
Table 77. Genentech Business Overview
Table 78. Genentech Personalized Cancer Treatment Product
Table 79. Genentech Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 80. Genentech Recent Development
Table 81. BMS Company Details
Table 82. BMS Business Overview
Table 83. BMS Personalized Cancer Treatment Product
Table 84. BMS Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 85. BMS Recent Development
Table 86. OHC - Oncology Hematology Care Company Details
Table 87. OHC - Oncology Hematology Care Business Overview
Table 88. OHC - Oncology Hematology Care Personalized Cancer Treatment Product
Table 89. OHC - Oncology Hematology Care Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 90. OHC - Oncology Hematology Care Recent Development
Table 91. CTOAM Company Details
Table 92. CTOAM Business Overview
Table 93. CTOAM Personalized Cancer Treatment Product
Table 94. CTOAM Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 95. CTOAM Recent Development
Table 96. Aadi Bioscience Company Details
Table 97. Aadi Bioscience Business Overview
Table 98. Aadi Bioscience Personalized Cancer Treatment Product
Table 99. Aadi Bioscience Revenue in Personalized Cancer Treatment Business (2020-2025) & (US$ Million)
Table 100. Aadi Bioscience Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Personalized Cancer Treatment Picture
Figure 2. Global Personalized Cancer Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Personalized Cancer Treatment Market Share by Type: 2024 VS 2031
Figure 4. Personalized Medical Diagnosis Features
Figure 5. Personalized Medical Treatment Features
Figure 6. Global Personalized Cancer Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Personalized Cancer Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Personalized Cancer Treatment Report Years Considered
Figure 11. Global Personalized Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Personalized Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Personalized Cancer Treatment Market Share by Region: 2024 VS 2031
Figure 14. Global Personalized Cancer Treatment Market Share by Players in 2024
Figure 15. Global Personalized Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Personalized Cancer Treatment Revenue in 2024
Figure 17. North America Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Personalized Cancer Treatment Market Share by Country (2020-2031)
Figure 19. United States Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Personalized Cancer Treatment Market Share by Country (2020-2031)
Figure 23. Germany Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Personalized Cancer Treatment Market Share by Region (2020-2031)
Figure 31. China Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Personalized Cancer Treatment Market Share by Country (2020-2031)
Figure 39. Mexico Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Personalized Cancer Treatment Market Share by Country (2020-2031)
Figure 43. Turkey Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Cellworks Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 47. Novartis Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 48. Gradalis, Inc Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 49. TherapySelect Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 50. Personalis Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 51. RGCC International Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 52. Genentech Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 53. BMS Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 54. OHC - Oncology Hematology Care Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 55. CTOAM Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 56. Aadi Bioscience Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232